CD4 and neoplasm: Overall sharing of TCR clonotypes from neoantigen-specific peptide expanded cultures and tumor tissue was 12% (n=21 CD8 and n=15 CD4) and 14% (n=95 CD8 and n=40 CD4) for primary tumor and metastasis, respectively.